This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Utz Brands (UTZ) Soars 88.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Utz Brands (UTZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
UTZNegative Net Change DARPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
New Era Energy & Digital, Inc. (NUAI) Surges 14.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
New Era Energy & Digital, Inc. (NUAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
NUAINegative Net Change CCJNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Karyopharm Therapeutics (KPTI) Soars 5.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Karyopharm Therapeutics (KPTI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
KPTINegative Net Change AUPHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ivanhoe Electric (IE) Soars 16.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ivanhoe Electric (IE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IENegative Net Change MTRNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tutor Perini (TPC) Surges 7.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Tutor Perini (TPC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TPCNegative Net Change MTZNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Forward Air (FWRD) Surges 22.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Forward Air (FWRD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
FWRDNegative Net Change SAIANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
EuroDry (EDRY) Surges 7.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
EuroDry (EDRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EDRYNegative Net Change HMRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nuvation Bio (NUVB) Soars 7.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nuvation Bio (NUVB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NUVBNegative Net Change ENTANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ABM Industries (ABM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ABMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
IREN Limited (IREN) Soars 19.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
IREN Limited (IREN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IRENNegative Net Change STEPNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today